A*STAR Singapore Immunology Network (A*STAR SIgN)

Researchers discover that the deletion of a gene linked to glucose metabolism leads to smaller pancreatic tumours and better patient survival.

New gastric cancer insights come to light with the help of powerful single-cell technologies.

Using improved mouse models for gastric cancer, A*STAR scientists uncover a pool of cancer stem cells key to disease progression.

Remdesivir treatment is more likely to be successful in COVID-19 patients who are naturally able to mount a strong immune response against infections.

By identifying the best way to decontaminate N95 masks, A*STAR scientists are helping solve the environmental consequences of disposable masks.

A novel molecular mechanism by which a malarial parasite enters host cells may broaden possibilities in malaria vaccine development.

The first open-access database of mononuclear phagocytes, created by A*STAR researchers, provides insight into the biology of these immune cells and their roles in fighting disease.

A*STAR researchers challenge existing theories around intestinal stem cell biology using a newly developed animal model of intestinal regeneration.

In the pursuit of scientific excellence, the current scholars of the A*STAR Graduate Academy hope to harness their education to contribute to Singapore’s scientific ecosystem.

Research reveals the safety of mRNA COVID-19 vaccines for breastfeeding mothers and the potential of passing immune protection to the baby.

During the 2018 outbreak in Southeastern Tanzania, there were four dengue virus serotypes and the chikungunya virus in circulation, say A*STAR researchers.

A new link between gene variations in immune cells and allergic reactions explains why some individuals are more prone to developing asthma.